Manuel Calaza

The paper identifies de novo mutations in ASD, distinguishing between germinal and postzygotic mutations and their biological roles across different developmental stages and brain regions.

The paper presents a large-scale cancer pharmacogenomic screen with 11,576 experiments on 910 drug combinations across 85 cancer cell lines, enabling crowd-sourced prediction of synergistic drug pairs and biomarkers.